Vanta Bioscience is currently trading at Rs. 129.85, up by 11.15 points or 9.39% from its previous closing of Rs. 118.70 on the BSE.
The scrip opened at Rs. 129.85 and has touched a high and low of Rs. 129.85 and Rs. 129.85 respectively. So far 750 shares were traded on the counter.
The BSE group ‘M’ stock of face value Rs. 10 has touched a 52 week high of Rs. 195.50 on 08-Mar-2021 and a 52 week low of Rs. 105.00 on 24-Nov-2021.
Last one week high and low of the scrip stood at Rs. 129.25 and Rs. 118.00 respectively. The current market cap of the company is Rs. 74.92 crore.
The promoters holding in the company stood at 69.00% and Non-Institutions held 31.00%.
Vanta Bioscience has received an order of Rs 1.18 crore from Coromandel International, India for carrying out various preclinical studies/toxicity studies on animals, agrochem studies and other studies. This prestigious order also marks the official initiation of studies of the company’s Physchem vertical. The said studies will be carried out by the company from its state of art research facility at Gummidipundi, Chennai.
Vanta Bioscience engages in the business of research and experimental development on natural sciences and engineering.